Marzena Niczyporuk-Furtak
Chodźki Street 1
Lublin, LU 20093, Poland
Lublin, LU 20093, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pathogenesis and Possible Consequences of Port-Site Metastasis in Gynecologic Oncology After Laparoscopic Procedures.
Journal: Cancer management and research
Published: January 03, 2025
Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: October 21, 2024
Correction: AOTMiT reimbursement recommendations compared to other HTA agencies.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: August 09, 2024
The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme.
Journal: Cells
Published: November 10, 2023
AOTMiT reimbursement recommendations compared to other HTA agencies.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: February 02, 2023
Reimbursement decision-making system in Poland systematically compared to other countries.
Journal: Frontiers in pharmacology
Published: January 29, 2023
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: November 28, 2022
Colorectal Cancer-The Worst Enemy Is the One We Do Not Know.
Journal: International journal of environmental research and public health
Published: November 23, 2022
Two years of the COVID-19 pandemic from a child's perspective: A narrative review.
Journal: Dental and medical problems
Published: August 05, 2022
A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy.
Journal: Journal of clinical medicine
Published: August 12, 2021
Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.
Journal: Journal of clinical medicine
Published: March 03, 2021
Last Updated: 09/26/2026